CLINICAL RESEARCH IN PERIPHERAL ARTERIAL DISEASE

The summary for the CLINICAL RESEARCH IN PERIPHERAL ARTERIAL DISEASE Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	CLINICAL RESEARCH IN PERIPHERAL ARTERIAL DISEASE
	CFDA Number:	93.837
	CFDA Description:	Heart and Vascular Diseases Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-HL-03-003
	Document Type:	Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	Oct 15, 2002
	Creation Date:	Mar 28, 2003
	Original Closing Date for Applications:	Feb 26, 2003
	Current Closing Date for Applications:	Information not provided
	Archive Date:	Mar 28, 2003
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	Information not provided
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Individuals For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Information not provided
Grant Description: This program aims to develop improved therapeutic and preventive approaches for atherosclerotic arterial diseases of the peripheral vasculature through integrated, multi-disciplinary clinical research projects. Key objectives include elucidating biological mechanisms related to the initiation, progression, and outcomes of disease; enhancing early detection by developing improved biomarkers, imaging approaches, and other relevant biomedical technologies; and developing novel therapeutic and preventive strategies.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-03-003.html http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-03-003.html
Grant Announcement Contact: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster OERWebmaster@od.nih.gov NIH OER Webmaster
Similar Government Grants: • Reducing the Impact of Hypertension in Low and Middle Income Countries (U01); • Data Coordinating Center for the Cardiovascular Cell Therapy Research Network (CCTRN) (UM1); • Regional Clinical Centers for the Cardiovascular Cell Therapy Research Network (CCTRN) (UM1); • Pilot Studies to Develop and Test Novel, Low- Cost Methods for the Conduct of Clinical Trials (R01); • Pulmonary Vascular-Right Ventricular Axis Research Program (R01); • The Relationship Between Hypertension and Inflammation; • Community-Responsive Interventions to Reduce Cardiovascular Risk in American Indians and Alaska Nati...; • Weight Loss in Obese Adults with Cardiovascular Risk Factors: Clinical Interventions (U01); • SPECIALIZED CENTERS OF CLINICALLY ORIENTED RESEARCH (SCCOR) IN CARDIAC DYSFUNCTION AND DISEASE; • PARTNERSHIP PROGRAMS TO REDUCE CARDIOVASCULAR DISPARITIES